If we can salvage this much out of all of this, why not.

Perhaps Bear is going through all of today's comments and may get around responding to this one. This is one of the BOM trial secondary endpoints.

Six hundred-plus patients were on apabetalone + Rosuvastatin(Crestor) and six hundred + on placebo + Rosuvastatin (Crestor). 

BOM trial had a much bigger patient sample than the Phase 2b ASSURE clinical trial which netted good results.

Koo